PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “MACROGLOBULINS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 721 records · Page 40Linked to original sources

Evolution of human alpha 2-macroglobulin.

A papain-binding protein (PBP) resembling human alpha 2-macroglobulin (alpha 2M) but of Mr half that of alpha 2M was purified from plaice (Pleuronectes platessa L.) plasma. The plaice protein displayed most of the distinctive inhibitory properties of the human macroglobulin, and was therefore considered, despite its smaller molecular size, to be homologous with alpha 2M. Plaice PBP was shown to consist of four dissimilar subunits; two I chains (Mr 105 000) and two II chains (Mr 90 000). Each of the larger I chains contained a "bait region" sensitive to proteolytic attack by a variety of proteinases, and an autolytic site analogous to the autolytic site of alpha 2M. Subunit I, almost certainly at the autolytic site, formed SDS-stable, covalent links with methylamine or a proportion of the trapped proteinase molecules. A scheme is proposed for the evolution of human alpha 2M from the smaller fish protein, and the possibility of a shared evolutionary origin for alpha 2M and the complement components C3 and C4 is discussed.

Amino Acid Sequence↗

[Alpha 2-macroglobulin: structure, properties and physiological role].

The paper is concerned with the results of recent researches devoted to studies of the structure, properties and physiological role of alpha 2-macroglobulin, one of main inhibitors of blood proteolytic enzymes. Data are presented on its primary and quaternary structure, mechanisms of interaction with proteinases. The role of alpha 2-macroglobulin in regulation of the activity of proteinases participating in blood coagulation, fibrinolysis, kininogenesis, immune reactions is shown. Possibilities of its application in medicine are discussed.

Amino Acid Sequence↗

[Experimental study of the antiproteinase activity of human alpha-2-macroglobulin concentrate].

20 series of alpha-2-macroglobulin (alpha 2-M) preparations with a specific activity of 15 +/- +/- 1 IU/mg were obtained by means of semi-industrial fractionation of human blood plasma Kohn 111 residue including polyethylene glycol and ethanol treatment. The preparations obtained inhibited proteolytic enzymes of fibrinolytic, kinin and blood coagulation systems as well as plant and bacterial proteinases. After intravenous administration of the alpha 2-M preparation into rats at a dose of 850-11,000 IU/kg the globulin concentration was correspondingly increased by 23-25% in blood. The half-time of excretion of the alpha 2-M therapeutic dose (2,700-5,700 IU/kg) was about 6.6-13,9 hrs which was 9-20-times higher as compared with the corresponding value for contrical. In the experimental proteolysis (effect of trypsin at a dose of 470-6,670 KU/kg) preparation of alpha 2-M, administered at a dose of 2,000-6,000 IU/kg, exhibited a distinct antiprotease action with a 1.5-1.7-fold increase in the rate of inactivation and excretion of trypsin. The alpha 2-M preparation was shown to be highly effective in prophylactic treatment. The advantages of antiprotease drugs based on human alpha-2-macroglobulin are discussed.

Animals↗

[Alpha2-macroglobulin in diabetic disease and in its microangiopathic complications].

The role of alfa2-macroglobulin in diabetic microangiopathy pathogenesis is described. A study of the behaviour of this protein in a group of diabetic patients with and without microangiopathy and in a control group of healthy patients has been carried out. It has been found that the protein greatly increases in diabetic patients with microangiopathy. On the basis of these results, it is suggested that dosage of alfa2-macroglobulin can be a possible test for evaluating microangiopathic complications in diabetes.

Adolescent↗

[Physiologic inhibitors of blood coagulation. 2. Alpha 2-macroglobulin, alpha-antitrypsin and the C1 inhibitor of complement].

Three physiological inhibitors of blood coagulation - alpha-2-macroglobulin, alpha-1-antitrypsin, and C-1-inhibitor of complement - are dealt with in a brief survey. The point is that these are proteins of the organism with a defence character which are also able to inhibit an extraordinarily broad spectrum of proteases. Some recent findings about their molecular structure, manner of response, and inhibitory spectrum are represented. Comparisons are made to corresponding proteins in mammals, in alpha-2-macroglobulin and even in lower vertebrates. Moreover, the inherited deficiency of these three inhibitors are represented with respect to human diseases and changes of their blood level in the course of various diseases are referred to.

Animals↗

Regulation of macrophage agglutination factor production by alpha 2-macroglobulin.

Alpha-2-macroglobulin (alpha 2M) is a major mammalian plasma proteinase inhibitor and a well-established suppressor of T cell blastogenesis. Its role in modulating T cell-mediated lymphokine production is less well documented. We have isolated and characterized guinea-pig plasma alpha 2M in order to study its role in regulating the elicitation of macrophage agglutination factor (MAggF), a T cell-dependent inflammatory lymphokine closely related to fibronectin. Alpha-2-macroglobulin was purified by a combination of gel chromatography and immunoadsorption to remove contaminating IgM. Purified alpha 2M showed a double band on polyacrylamide gel electrophoresis. It had a molecular weight of 714,000 which fell to 190,000 on reduction, a pI of 4.8 and bound up to 1.3 moles of trypsin or elastase per mole. The elicitiation of MAggF from 25 X 10(6) purified protein derivative (PPD)-stimulated guinea-pig lymph node cells was inhibited 99% by 2-3 micrograms of biologically active alpha 2M only if the proteinase inhibitor was added to the lymph node cells at the same time as antigen. No inhibition of MAggF production was observed when active alpha 2M was added at the end of culture or when biologically inactive alpha 2M was added to the cultures at any time. MAggF was not elicited from normal cells by PPD, nor did alpha 2M have any effect on these cultures. Purified alpha 2M had no direct effect on MAggF activity in culture supernatants. We suggest that alpha 2M may be involved in modulating antigen-elicited lymphokine production in vivo.

Animals↗

Appendix. Structural predictions on alpha 2-macroglobulin from the amino acid sequence.

The composite result from three different methods predicts that alpha 2-macroglobulin has a predominant pattern of alternating beta-strands and turns. Only scattered pieces of alpha-helix are present throughout its sequence. Predicted beta-strands constitute 43.8% and helices 8.6%, in fair agreement with circular dichroism spectra. Circular dichroism spectra and sequence data suggest that the tertiary structure of complement component C3b is similar to that of the alpha 2 macroglobulin monomer. At present, the beta-barrel configuration of prealbumin seems to be a better model than those of soybean trypsin inhibitor, serine proteases, and immunoglobulins. A repetitive pattern of disulfide loops could indicate structural units of about 200 residues in size, but this is not supported by amino acid sequence homology. The hydropathic pattern of the sequence reveals numerous examples of predicted immunogenic peptides and detects an approximately 100-residue hydrophobic core region, which could constitute parts of the tentatively assigned consecutive activation cleavage and thiol ester domains. This core is an obvious candidate of rearrangement transfer between the highly exposed bait region and the partly shielded thiol ester site. The presumed intersubunit half-cystine is moderately buried and has two nearby patches of high charge density which could guide the dimeric assembling.

Amino Acid Sequence↗

[Preparative isolation of alpha 2-macroglobulin, transferrin, albumin and study of their nonspecific gamma-inhibitory activity].

Profiles of distribution of non-specific gamma-inhibitors of influenza A2/Victoria/35/72 in donkey and horse sera were established by gel chromatography in Sephadex G-200. High and low molecular inhibitors were found in 19S and 4S serum fractions. Highly purified preparations of a2-macroglobulin, transferrine and albumin were isolated by a combination of methods of salt precipitation, gel chromatography on Sephadex G-100, G-200 and ion exchange on DEAE-Sephadex A-50. Heating sera resulted in a considerable increase of the antiviral activity of a2-macroglobulin and transferrine and a reduction of albumin activity.

Animals↗

Stability and subunit structure of human alpha2-macroglobulin.

The molecular weights of alpha2-macroglobulin and its non-covalent subunits have been determined by equilibrium centrifugation. The secondary structure of the native and the thermally denatured molecules has been analyzed by circular dichroic measurements. In contrast to most proteins the thermally denatured form contains a slightly more highly organized polypeptide chain than the native form. The relaxation time of the native protein, as determined by fluorescence polarization measurements, indicates that alpha2-macroglobulin is composed of domains smaller than that of the two subunits. The transitions in acid, alkali, and at high temperatures have been explored in order to establish the pH and thermal range of stability of alpha-macroglobin.

Drug Stability↗

Amino acid composition of the mu chains of IgM of normal serum, monoclonal cryoglobulin and Waldenstrom macroglobulin.

The purified IgM of normal human serum, monoclonal cryoglobulin and Waldenstrom macroglobulin were reduced, alkylated and subjected to Sephadex G-100 filtration. The mu chains separated were hydrolysed and analysed for amino acid content. In both monoclonal proteins the content of hydroxyproline in mu chains was lower than in the IgM of normal serum. The mu chain of monoclonal cryoglobulin contained less serine, methionine and tyrosine, whereas mu chains of Waldenstrom macroglobulin showed a lower level of cystine as compared with the IgM of normal serum. On the other hand, the content of valine and basic amino acids was higher in both monoclonal proteins.

Amino Acids↗

A naturally occurring complement dependent human IgM macroglobulin inhibitory to Ehrlich ascites tumor cells.

Human serum and the sera of a number of other mammalian species contain a naturally occurring macroglobulin with antibody-like properties which, in the presence of complement, is cytotoxic to murine Ehrlich ascites tumor cells in vitro. The serum of guinea pigs, rats and mice lack this macroglobulin activity but serve well as complement sources. The cytotoxic activity was demonstrated in short-term tissue cultures of Ehrlich ascites tumor cells by the marked and immediate inhibition of nucleic acid and protein synthesis. The cytotoxic activity is independent of the lytic antibody system which reacts against neuraminidase-treated lymphocytes.

Animals↗

[Study of various serum proteins in lung cancer. Immunoglobulins A, G, M, haptoglobin, alpha-1-antitrypsin, alpha-2-macroglobulin].

A statistical study of the plasma concentration of immunoglobulin, alpha-1-antitrypsin, haptoglobin, and alpha-2-macroglobulin in 153 patients with primary carcinoma of the lung showed a strong increase in alpha-1-antitrypsin, haptoglobin and A and C immunoglobulins, whilst alpha-2-macroglobulin increases very moderately, and IgM does not vary. The relationships between variables are also modified, thus there appears a correlation between IgA and IgG to the detriment of the IgG/IgM relationship. Furthermore the coefficient of the correlation IgG/alpha-2-macroblobulin is lower in cancer patients.

Female↗

Adjuvant-free in vivo targeting. Antigen delivery by alpha 2-macroglobulin enhances antibody formation.

The proteinase "inhibitor" alpha 2-macroglobulin (alpha 2M) is able to entrap and form covalent linkages with diverse proteins during a transient proteinase-activated state. These complexes are rapidly endocytosed after binding to receptors present on macrophages and other cells. We have previously shown that compared to free hen egg lysozyme (HEL), alpha 2M-complexed HEL undergoes enhanced macrophage uptake, processing, and presentation to T hybridoma clones in vitro. Inasmuch as it is not clear whether T hybridoma responses accurately reflect primary immune responses in vivo, we studied antibody production in rabbits using two Ag complexed with either human alpha 2M (H alpha 2M) or a homologous protein purified from rabbit plasma, alpha 1-macroglobulin (R alpha 1M). Pathogen-free NZW rabbits received s.c. injections with adjuvant-free preparations of free HEL or porcine pancreatic elastase (PPE), H alpha 2M-HEL-PPE complexes, R alpha 1M-HEL-PPE complexes, or mixtures of the uncomplexed proteins. Complexing the Ag to alpha 2M resulted in 10 to 500-fold higher IgG titers compared to uncomplexed controls. Injection of Ag complexed to either H alpha 2M or R alpha 1M resulted in levels of anti-HEL IgG comparable to those elicited by emulsification in CFA. Inasmuch as inflammatory proteinases such as neutrophil elastase can initiate covalent complex formation with alpha 2M, we propose that "proteinase-activated" alpha 2M may mediate receptor-enhanced Ag uptake by macrophages, resulting in augmented Ag processing and antibody production.

Animals↗

Cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase.

Lipoprotein lipase (LPL) binds to the low density lipoprotein receptor-related protein (LRP)/alpha 2-macroglobulin receptor and induces catabolism of normal human very low density lipoproteins (VLDL) via LRP in vitro. Recent studies showed that the C-terminal domain of LPL can bind LRP in solid phase assays and inhibit cellular catabolism of two LRP ligands, activated alpha 2-macroglobulin and the 39-kDa receptor-associated protein (Williams, S.E., Inoue, I., Tran, H., Fry, G. L., Pladet, M.W., Iverius, P.-H., Lalouel, J.-M., Chappell, D.A., and Strickland, D.K. (1994) J. Biol. Chem. 269, 8653-8658). The current study investigated the potential for this region of LPL to promote cellular catabolism of VLDL via LRP. A fragment comprising the C-terminal domain of LPL (designated LPLC) was expressed in bacteria and found to promote cellular binding, uptake, and degradation of normal human VLDL in a dose-dependent manner. These effects were present whether LPLC was added simultaneously with 125I-VLDL or was prebound to cell surfaces prior to the assay. Mutations involving Lys407, Trp393, Trp394, or deletion of the C-terminal 14 residues reduced the effects of LPLC. Three LRP-binding proteins, the receptor-associated protein, lactoferrin, and a polyclonal antibody against LRP, competed for 125I-VLDL degradation induced by LPLC. Heparin or heparinase treatment of cells prevented LPLC-induced 125I-VLDL catabolism. Thus, cell-surface proteoglycans play an important role in this pathway. Interestingly, either LPLC or LPL when added in excess could block LPL-induced 125I-VLDL degradation presumably by interacting directly with LRP. However, unlabeled VLDL could not prevent catabolism of 125I-labeled LPLC or LPL. These data show that cellular fates for VLDL versus LPLC or LPL are divergent. This is probably due to independent catabolism of the latter via cell-surface proteoglycans. In summary, these in vitro studies indicate that a fragment of LPL corresponding to the C-terminal domain mimics the native enzyme with respect to induction of VLDL catabolism via LRP. Because LPLC lacks the catalytic site of native LPL, these studies establish that lipase activity is not required for LRP-mediated lipoprotein catabolism.

Binding, Competitive↗

Comparison of the postoperative fibrinogen, alpha-1-antitrypsin and alpha-2- macroglobulin concentrations in the blood of wounded soldiers of Croatian Army and peacetime injured civilians.

In 10 wounded Croatian Army soldiers and in 10 civilians with accidental musculosceletal traumatisation, blood concentrations of the 3 acute phase proteins: fibrinogen, alpha-1-antitrypsin and alpha-2-macroglobulin on the 1st, 5th and 10th postoperative day were assessed. On the 5th day after injury, increased concentrations of all 3 acute phase proteins (APP) were found in all patients. The rise of the fibrinogen concentrations in the wounded soldiers was the steepest. On the 10th day after wounding, fibrinogen concentrations in the gorup of wounded soldiers were significantly lower than those in the group of injured civilians. On the 10th day after wounding there were no differences between the 2 groups in the concentrations of alpha-1-antitrypsin and of alpha-2-macroglobulin. The lower fibrinogen concentrations in the wounded soldiers could be explained by the modulation of the general reactivity of the organism to injury, proposed by Woloski, which is induced by stress and microtrauma on battlefield before the wounding.

Adult↗

Changes in tissue distribution of rat alpha 1-macroglobulin and pregnancy-associated alpha 1-glycoprotein after inflammatory injury.

Antiserum against rat alpha 1-macroglobulin (alpha 1MG) was produced in rabbits. Antiserum against rat pregnancy-associated alpha 1-glycoprotein (PAG) was obtained by immunization with a partly purified PAG preparation and absorption of the serum with male rat serum. Acute inflammation was produced in non-pregnant female rats by a single intramuscular injection of turpentine. The concentrations of both macroglobulins in the serum and in tissue extracts were measured by rocket immunoelectrophoresis at various times up to 7 days after injury. Inflammation produced in the rats resulted in moderately elevated serum levels of these proteins soon after injury. At first, alpha 1MG levels in a number of tissues (heart, lung, kidney, spleen, pancreas, uterus and ovary) were depressed markedly; they then stabilized. The elevated serum concentrations of alpha 1MG remained unchanged during inflammation. The store of PAG in the tissues was rapidly depleted and its serum level decreased to a normal value 7 days after injury. Our findings indicate that alpha 1MG plays a more important role in maintenance of the proteinase inhibitory potential in the rat than does PAG.

Acute-Phase Reaction↗

[Concentration of plasmin complexes with alpha-2-macroglobulin and alpha-2-antiplasmin in blood plasma and serum].

A methodological approach has been developed for measuring the concentrations of proteinase complexes with their inhibitors in various biological fluids. This approach is based on the use of polyclonal antibodies to the complex complements and their detection by enzyme immunoassay. Appreciable individual differences in the levels of alpha 2-macroglobulin and plasmin in donor blood plasma samples were revealed. Complexes of this inhibitor with plasmin are responsible for about 3% of the total alpha 2-macroglobulin pool in blood plasma and sera.

Antifibrinolytic Agents↗